{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T11:26:15Z","timestamp":1783250775350,"version":"3.54.6"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5P30GM103398-03"],"award-info":[{"award-number":["5P30GM103398-03"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0162404","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T18:21:08Z","timestamp":1473445268000},"page":"e0162404","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Huntingtons Disease Mice Infected with Toxoplasma gondii Demonstrate Early Kynurenine Pathway Activation, Altered CD8+ T-Cell Responses, and Premature Mortality"],"prefix":"10.1371","volume":"11","author":[{"given":"David W.","family":"Donley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merl F.","family":"Raisbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Gigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"L Cui","year":"2006","journal-title":"Cell"},{"issue":"Pt 7","key":"ref3","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"YF Tai","year":"2007","journal-title":"Brain: a journal of neurology"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"M Bjorkqvist","year":"2008","journal-title":"The Journal of experimental medicine"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"NS Wexler","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"E Sapp","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study","volume":"32","author":"M Politis","year":"2011","journal-title":"Hum Brain Mapp"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1172\/JCI64565","article-title":"Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression","volume":"122","author":"A Weiss","year":"2012","journal-title":"J Clin Invest"},{"issue":"Pt 3","key":"ref9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/brain\/awt355","article-title":"HTT-lowering reverses Huntington's disease immune dysfunction caused by NFkappaB pathway dysregulation","volume":"137","author":"U Trager","year":"2014","journal-title":"Brain: a journal of neurology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers","volume":"83","author":"M Politis","year":"2015","journal-title":"Neurobiology of disease"},{"key":"ref11","first-page":"388","article-title":"Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models","volume":"73C","author":"U Trager","year":"2014","journal-title":"Neurobiology of disease"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/aje\/154.4.357","article-title":"Toxoplasma gondii infection in the United States: seroprevalence and risk factors","volume":"154","author":"JL Jones","year":"2001","journal-title":"Am J Epidemiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-5-48","article-title":"Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection","volume":"5","author":"G Hermes","year":"2008","journal-title":"Journal of neuroinflammation"},{"issue":"4851","key":"ref14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-gamma: the major mediator of resistance against Toxoplasma gondii","volume":"240","author":"Y Suzuki","year":"1988","journal-title":"Science"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/IAI.70.2.779-786.2002","article-title":"L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase","volume":"70","author":"S Fujigaki","year":"2002","journal-title":"Infection and immunity"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1128\/IAI.62.6.2277-2284.1994","article-title":"Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts","volume":"62","author":"SL Gupta","year":"1994","journal-title":"Infection and immunity"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/978-1-4615-4709-9_66","article-title":"Cytokine mediated regulation of interferon-gamma-induced IDO activation","volume":"467","author":"CR MacKenzie","year":"1999","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"P Guidetti","year":"2004","journal-title":"Neurobiology of disease"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","article-title":"The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease","volume":"21","author":"S Campesan","year":"2011","journal-title":"Current biology: CB"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"D Zwilling","year":"2011","journal-title":"Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nbd.2014.06.022","article-title":"Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model","volume":"71","author":"Z Lu","year":"2014","journal-title":"Neurobiology of disease"},{"issue":"3","key":"ref22","first-page":"397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"G Schilling","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1128\/IAI.00649-09","article-title":"Long-term immunity to lethal acute or chronic type II Toxoplasma gondii infection is effectively induced in genetically susceptible C57BL\/6 mice by immunization with an attenuated type I vaccine strain","volume":"77","author":"JP Gigley","year":"2009","journal-title":"Infection and immunity"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2005-03-0979","article-title":"A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation","volume":"106","author":"D Braun","year":"2005","journal-title":"Blood"},{"issue":"20","key":"ref25","doi-asserted-by":"crossref","first-page":"14457","DOI":"10.1016\/S0021-9258(17)36645-0","article-title":"Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes","volume":"269","author":"SR Thomas","year":"1994","journal-title":"J Biol Chem"},{"issue":"22","key":"ref26","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1073\/pnas.1015298108","article-title":"Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade","volume":"108","author":"R Bhadra","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/infdis\/jis304","article-title":"PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection","volume":"206","author":"R Bhadra","year":"2012","journal-title":"J Infect Dis"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4049\/jimmunol.182.2.1069","article-title":"Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication","volume":"182","author":"JP Gigley","year":"2009","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.exppara.2011.10.004","article-title":"Toxoplasma gondii: determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts","volume":"130","author":"WK Chew","year":"2012","journal-title":"Exp Parasitol"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1128\/IAI.67.11.5869-5876.1999","article-title":"Immune CD8(+) T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host","volume":"67","author":"IA Khan","year":"1999","journal-title":"Infection and immunity"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/acps.12423","article-title":"Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis","volume":"132","author":"AL Sutterland","year":"2015","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2010.03.057","article-title":"The probable relation between Toxoplasma gondii and Parkinson's disease","volume":"475","author":"O Miman","year":"2010","journal-title":"Neurosci Lett"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/00365541003716500","article-title":"Is there a relationship between Toxoplasma gondii infection and idiopathic Parkinson's disease?","volume":"42","author":"T Celik","year":"2010","journal-title":"Scandinavian journal of infectious diseases"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WAD.0b013e3181f73bc2","article-title":"Could Toxoplasma gondii have any role in Alzheimer disease?","volume":"25","author":"OY Kusbeci","year":"2011","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/WAD.0000000000000108","article-title":"Seroprevalence and Serointensity of Latent Toxoplasma gondii in a Sample of Elderly Adults With and Without Alzheimer Disease","volume":"30","author":"CE Perry","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","article-title":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease","volume":"30","author":"W Duan","year":"2008","journal-title":"Neurobiology of disease"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2004.01.003","article-title":"Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice","volume":"187","author":"G Schilling","year":"2004","journal-title":"Experimental neurology"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"e0141793","DOI":"10.1371\/journal.pone.0141793","article-title":"Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington's Disease T Lymphocytes","volume":"10","author":"JR Miller","year":"2015","journal-title":"PloS one"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"R Schwarcz","year":"2012","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/jnc.12350","article-title":"Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease","volume":"127","author":"G Mazarei","year":"2013","journal-title":"Journal of neurochemistry"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"JD Mezrich","year":"2010","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"965046","DOI":"10.1155\/2013\/965046","article-title":"Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host\/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders","volume":"2013","author":"CJ Carter","year":"2013","journal-title":"J Pathog"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"JS Steffan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 3","key":"ref44","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease","volume":"139","author":"L Boussicault","year":"2016","journal-title":"Brain: a journal of neurology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0162404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T01:40:50Z","timestamp":1657244450000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0162404"}},"subtitle":[],"editor":[{"given":"Laura J","family":"Knoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0162404","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}